who created semaglutide Drug maker Novo Nordisk has announced that its weight-loss drug failed to slow down the decline in memory and thinking in people with early Alzheimer's disease. This disappointing news will come Interview with Weight Loss Drugs

GLP-1s are a class of medications designed to aid in weight loss and blood sugar management, which can indirectly have positive effects on fertility

The bottom line The TL;DR is this: Theres a lot of excitement around GLP-1s and their potential longevity benefits, but its still way too early to say the general population should start taking them for those purposes

You need to position your brands as relevant, cost-conscious solutions whether they are actively losing pounds or looking to maintain their weight loss through a high-protein, low carb diet. Not a Fad: Investing in New Offerings and Packaging Big CPG brands are already making big bets on meal and nutrient replacements for those consuming less

doi: 10.1016/j.isci.2023.107379 84 WirkaRCWaghDPaikDTPjanicMNguyenTMillerCLet al

As hypoglycemia progresses, central nervous system effects emerge: headache, dizziness, mental dullness, confusion, and even amnesia